TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Other EventsItem 8.01 related to the Press Release, including exhibit 99.01, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Item 8.01 related to the Press Release shall not be incorporated by reference into any registration statement or other document to the Securities Act of 1933, except as shall be expressly set forth by specific reference in any such filing, and is not deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.
A copy of the Company’s common stock certificate is filed as Exhibit 4.1 to this Current Report on Form 8-K.
| Item 9.01 | Financial Statements and Exhibits. |
* Filed herewith.
** Furnished herewith.
Tonix Pharmaceuticals Holding Corp. Exhibit…To view the full exhibit click here